News

Displaying 921 - 930 of 1706 Articles
MS Ireland/Novartis
19 Sep 2016

Siponimod

Novartis BAF312 reduces the risk of disability progression in pivotal phase III study in secondary progressive Multiple Sclerosis patients

MS Ireland
05 Sep 2016

UPDATE: AGM 2016

If you are a member of MS Ireland, you will have received the AGM notice and information pack together with the new Constitution and Proxy Form as referred in the Notice of the AGM, please see below further information.

Top